Expanding Treatment Options for CLL

A Town Meeting for Patients, Their Families & Care Partners

September 23, 2017


An audience of CLL patients and their caregivers joined us at a recent town meeting along with CLL Global Research Foundation to hear the latest treatment and research news, inspiring stories of people living well with CLL, tips for effective communication with a healthcare team and more.

We are also planning events in other cities. If you haven’t already, please sign up for email updates so we can alert you when important and inspiring videos become available and when upcoming town meetings are scheduled.

 

Patient Folder

 

 


Decoding Monoclonal Antibodies

What are monoclonal antibodies targeting in the fight against CLL? Dr. Stephen Spurgeon and Dr. Jeff Sharman decode this group of therapies.

Published:

Expanding Treatment Options for CLL: Session Two Replay

Watch the replay of session two of our “Expanding Treatment Options for CLL” town meeting as CLL experts are joined by a social worker and inspiring patients to discuss tools for living well with CLL.

Published:

Expanding Treatment Options for CLL: Session One Replay

Watch the replay of session one of our “Expanding Treatment Options for CLL” town meeting as a panel of experts discuss the latest in CLL research.

Published:

Host & Guests
Host

Host, Patient Power Co-Founder, CLL Patient and Advocate


Guests

Medical Oncologist, Willamette Valley Cancer Institute and Research Center; Medical Director, The US Oncology Network


Hematologist/Oncologist


Associate Professor of Medicine; Section Head, Hematologic Malignancies

OHSU Knight Cancer Institute



This town meeting was provided by CLL Global Research Foundation, which received support from AbbVie Inc., Gilead Sciences, TG Therapeutics, Pharmacyclics LLC and Janssen Biotech, Inc., and Genentech. It was produced by Patient Power in collaboration with The US Oncology Network, Compass Oncology, and Willamette Valley Cancer Institute and Research Center.


Page last updated on November 21, 2017